CLINICAL_TRIALS trial_result · 2015-12-08

Clinical Trial Update: A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma [Phase 1]

Phase 1 pharmacokinetic and metabolism study of radiolabeled RO5185426 in patients with metastatic melanoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2015-12-08